Gefitinib Tablet is a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC), especially in patients with specific EGFR mutations. Gefitinib Tablet works by blocking signals that promote cancer cell growth, helping to slow disease progression.
With its precision-based approach, it offers effective and personalized cancer care under specialist supervision.
